Lung cancer awareness month is celebrated every year in the month of November. Smoking remains the leading cause behind lung cancer but experts are now seeing a sharp rise of lung cancer…
Tag: Lung Cancer Awareness
Lung Cancer Awareness Month: Tips to Reduce your Risk
Every year, lung cancer awareness month is observed in November to educate public about lung cancer, encourage prevention and promote its early detection. White ribbon is used to symbolize the fight against…
Toenails to Reveal Exposure to Lung Cancer Cause
Although smoking remains the root cause behind lung cancer, but it is also rising among non-smokers. The other causes include exposure to radon, second-hand smoke, explosives and more. Radon is a colorless…
Lurbinectedin Combination gets FDA Approval for Extensive-Stage SCLC
The U.S. Food and Drug Administration (FDA) has approved lurbinectedin (Zepzelca) in combination with atezolizumab or and hyaluronidase-tqjs for adults with extensive-stage small cell lung cancer (ES-SCLC) without disease progression after frontline…
Understanding The Link Between Lung Cancer and Pneumonia
What is lung cancer? What is pneumonia? Lung cancer and pneumonia share various similar symptoms and thus, it becomes difficult to differentiate between the two. Pneumonia is a lung infection leading to…
FDA Grants Breakthrough Therapy to Olomorasib to Treat Lung Cancer
Eli Lilly and Company has announced that US Food and Drug Administration (FDA) has granted breakthrough therapy designation to olomorasib, in combination with anti-PD1 therapy Keytruda for first-line treatment of patients with…
Study Sheds Light on Rare Form of Lung Cancer
A rare and aggressive type of lung cancer called large cell neuroendocrine carcinoma (LCNEC) has a high chance of metastasis. It has no standard treatment and thus, suffer a poor survival rate….
FDA Approves Hernexeos for HER2-Mutant Advanced Lung Cancer
For the first time, FDA has given approval of an oral treatment of patients with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors have human epidermal growth factor receptor 2…